C142H183FN16O23S6 — CID 158382585
4-amino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;4-anilino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;1-[4-anilino-7-fluoro-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;1-[4-anilino-7-methyl-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;N-cyclopropyl-7-(hydroxymethyl)-4-[(4-methoxyphenyl)methylamino]-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;methane (PubChem CID 158382585) has the molecular formula C142H183FN16O23S6 and a molecular weight of 2693.51 g/mol. Its IUPAC name is 4-amino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;4-anilino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;1-[4-anilino-7-fluoro-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;1-[4-anilino-7-methyl-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;N-cyclopropyl-7-(hydroxymethyl)-4-[(4-methoxyphenyl)methylamino]-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;methane.
| Compound Name | 4-amino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;4-anilino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;1-[4-anilino-7-fluoro-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;1-[4-anilino-7-methyl-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;N-cyclopropyl-7-(hydroxymethyl)-4-[(4-methoxyphenyl)methylamino]-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;methane |
|---|---|
| PubChem CID | 158382585 |
| Molecular Formula | C142H183FN16O23S6 |
| Molecular Weight | 2693.51 g/mol |
| Exact Mass | 2691.20 |
| IUPAC Name | 4-amino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;4-anilino-N-cyclopropyl-7-(hydroxymethyl)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;1-[4-anilino-7-fluoro-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;1-[4-anilino-7-methyl-6-(2-propylsulfonylethyl)quinolin-3-yl]propan-1-one;N-cyclopropyl-7-(hydroxymethyl)-4-[(4-methoxyphenyl)methylamino]-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;N-cyclopropyl-7-(hydroxymethyl)-4-(methylamino)-6-(2-propylsulfonylethyl)quinoline-3-carboxamide;methane |
| SMILES | C.C.C.C.CCCS(=O)(=O)CCc1cc2c(N)c(C(=O)NC3CC3)cnc2cc1CO.CCCS(=O)(=O)CCc1cc2c(NC)c(C(=O)NC3CC3)cnc2cc1CO.CCCS(=O)(=O)CCc1cc2c(NCc3ccc(OC)cc3)c(C(=O)NC3CC3)cnc2cc1CO.CCCS(=O)(=O)CCc1cc2c(Nc3ccccc3)c(C(=O)CC)cnc2cc1C.CCCS(=O)(=O)CCc1cc2c(Nc3ccccc3)c(C(=O)CC)cnc2cc1F.CCCS(=O)(=O)CCc1cc2c(Nc3ccccc3)c(C(=O)NC3CC3)cnc2cc1CO |
| InChI | InChI=1S/C27H33N3O5S.C25H29N3O4S.C24H28N2O3S.C23H25FN2O3S.C20H27N3O4S.C19H25N3O4S.4CH4/c1-3-11-36(33,34)12-10-19-13-23-25(14-20(19)17-31)28-16-24(27(32)30-21-6-7-21)26(23)29-15-18-4-8-22(35-2)9-5-18;1-2-11-33(31,32)12-10-17-13-21-23(14-18(17)16-29)26-15-22(25(30)28-20-8-9-20)24(21)27-19-6-4-3-5-7-19;1-4-12-30(28,29)13-11-18-15-20-22(14-17(18)3)25-16-21(23(27)5-2)24(20)26-19-9-7-6-8-10-19;1-3-11-30(28,29)12-10-16-13-18-21(14-20(16)24)25-15-19(22(27)4-2)23(18)26-17-8-6-5-7-9-17;1-3-7-28(26,27)8-6-13-9-16-18(10-14(13)12-24)22-11-17(19(16)21-2)20(25)23-15-4-5-15;1-2-6-27(25,26)7-5-12-8-15-17(9-13(12)11-23)21-10-16(18(15)20)19(24)22-14-3-4-14;;;;/h4-5,8-9,13-14,16,21,31H,3,6-7,10-12,15,17H2,1-2H3,(H,28,29)(H,30,32);3-7,13-15,20,29H,2,8-12,16H2,1H3,(H,26,27)(H,28,30);6-10,14-16H,4-5,11-13H2,1-3H3,(H,25,26);5-9,13-15H,3-4,10-12H2,1-2H3,(H,25,26);9-11,15,24H,3-8,12H2,1-2H3,(H,21,22)(H,23,25);8-10,14,23H,2-7,11H2,1H3,(H2,20,21)(H,22,24);4*1H4 |
| InChIKey | GVZCHQHMEFBKGM-UHFFFAOYSA-N |
| XLogP | 23.80 |
| TPSA | 609.04 Ų |
| H-Bond Donors | 14 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 57 |
| Heavy Atoms | 188 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2693.51 |
| LogP ≤ 5 | 23.80 |
| H-Bond Donors ≤ 5 | 14 |
| H-Bond Acceptors ≤ 10 | 35 |